These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
492 related items for PubMed ID: 19155534
1. Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy. Xiao J, Leung JC, Chan LY, Guo H, Lai KN. Nephrol Dial Transplant; 2009 Jul; 24(7):2067-77. PubMed ID: 19155534 [Abstract] [Full Text] [Related]
2. Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy. Xiao J, Leung JC, Chan LY, Tang SC, Lai KN. Clin Immunol; 2009 Aug; 132(2):266-76. PubMed ID: 19443277 [Abstract] [Full Text] [Related]
3. Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy. Chan LY, Leung JC, Tang SC, Choy CB, Lai KN. J Am Soc Nephrol; 2005 Aug; 16(8):2306-17. PubMed ID: 15930094 [Abstract] [Full Text] [Related]
4. Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator-activated receptor-gamma agonist. Tang SC, Leung JC, Chan LY, Tsang AW, Lai KN. J Am Soc Nephrol; 2006 Jun; 17(6):1633-43. PubMed ID: 16687627 [Abstract] [Full Text] [Related]
5. Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA nephropathy. Chan LY, Leung JC, Tsang AW, Tang SC, Lai KN. Kidney Int; 2005 Feb; 67(2):602-12. PubMed ID: 15673307 [Abstract] [Full Text] [Related]
6. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells. Peng Y, Liu H, Liu F, Liu Y, Li J, Chen X. Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790 [Abstract] [Full Text] [Related]
7. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts. Zhang GY, Yi CG, Li X, Ma B, Li ZJ, Chen XL, Guo SZ, Gao WY. Br J Dermatol; 2009 Apr; 160(4):762-70. PubMed ID: 19120328 [Abstract] [Full Text] [Related]
8. Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury. Doi S, Masaki T, Arakawa T, Takahashi S, Kawai T, Nakashima A, Naito T, Kohno N, Yorioka N. Transplantation; 2007 Jul 27; 84(2):207-13. PubMed ID: 17667812 [Abstract] [Full Text] [Related]
9. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide. Sommer M, Wolf G. Am J Nephrol; 2007 Jul 27; 27(4):425-34. PubMed ID: 17622750 [Abstract] [Full Text] [Related]
10. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism. Moulin D, Bianchi A, Boyault S, Sebillaud S, Koufany M, Francois M, Netter P, Jouzeau JY, Terlain B. Arthritis Rheum; 2005 Mar 27; 52(3):759-69. PubMed ID: 15751073 [Abstract] [Full Text] [Related]
14. Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell. Xiao J, Chen W, Lu Y, Zhang X, Fu C, Yan Z, Zhang Z, Ye Z. Inflamm Res; 2015 Aug 27; 64(8):603-14. PubMed ID: 26072064 [Abstract] [Full Text] [Related]
16. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro. Liu JJ, Liu PQ, Lin DJ, Xiao RZ, Huang M, Li XD, He Y, Huang RW. Ann Hematol; 2007 Mar 27; 86(3):173-83. PubMed ID: 17089125 [Abstract] [Full Text] [Related]
20. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair. Schiefelbein D, Seitz O, Goren I, Dissmann JP, Schmidt H, Bachmann M, Sader R, Geisslinger G, Pfeilschifter J, Frank S. Mol Pharmacol; 2008 Oct 27; 74(4):952-63. PubMed ID: 18599600 [Abstract] [Full Text] [Related] Page: [Next] [New Search]